New York State Common Retirement Fund Oncternal Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.7 - $1.56 $10,710 - $23,868	-15,300 Reduced 97.58%	379 $0
Q4 2021 Feb 02, 2022	SELL	$2.27 - $4.39 $158 - $307	-70 Reduced 0.44%	15,679 $36,000
Q3 2021 Nov 02, 2021	SELL	$3.37 - $4.76 $74,648 - $105,438	-22,151 Reduced 58.45%	15,749 $66,000
Q2 2021 Aug 02, 2021	BUY	$4.75 - $9.39 $180,025 - $355,881	37,900 New	37,900 $180,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.